https://www.sciencedaily.com/news/health_medicine/multiple_sclerosis/ Information on multiple sclerosis. Read current research articles and learn about multiple sclerosis diagnosis, symptoms as well as the latest MS treatment options. en-us Tue, 21 Apr 2026 00:10:15 EDT Tue, 21 Apr 2026 00:10:15 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/multiple_sclerosis/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260414075648.htm A lifetime of mental stimulation—like reading, writing, and learning new skills—may help protect the brain as we age. People with the highest levels of cognitive enrichment had a much lower risk of Alzheimer’s and experienced symptoms years later than those with the lowest levels. Wed, 15 Apr 2026 04:09:05 EDT https://www.sciencedaily.com/releases/2026/04/260414075648.htm https://www.sciencedaily.com/releases/2026/04/260409101111.htm Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits. Scientists are now pushing toward multi-pronged strategies, from gene editing to brain-cell rejuvenation and gut health interventions. The goal: stop treating Alzheimer’s as one disease and start tackling it as a complex system. Fri, 10 Apr 2026 10:12:15 EDT https://www.sciencedaily.com/releases/2026/04/260409101111.htm https://www.sciencedaily.com/releases/2026/03/260330001129.htm A powerful cholesterol-lowering drug may be changing the rules of heart disease prevention. Researchers found that evolocumab, typically used for people who already have cardiovascular disease, can significantly cut the risk of first-time heart attacks and strokes in high-risk patients with diabetes—even before any artery-clogging plaque is detected. Mon, 30 Mar 2026 03:29:23 EDT https://www.sciencedaily.com/releases/2026/03/260330001129.htm https://www.sciencedaily.com/releases/2026/03/260328043554.htm A major new U.S. cholesterol guideline is shifting the focus toward earlier, more personalized prevention of heart disease. It urges people to start screening sooner—sometimes even in childhood—and highlights the importance of tracking not just LDL (“bad”) cholesterol but also genetic risk factors like lipoprotein(a). A new, more advanced risk calculator now uses broader health data to better predict heart attack and stroke risk over decades. Sun, 29 Mar 2026 05:43:08 EDT https://www.sciencedaily.com/releases/2026/03/260328043554.htm https://www.sciencedaily.com/releases/2026/03/260321012659.htm A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of injectable therapies. Because it’s taken orally, it could overcome one of the biggest barriers keeping patients from using current treatments. Researchers say many people still don’t reach safe cholesterol levels—even on statins—highlighting the need for better options. Sat, 21 Mar 2026 08:04:04 EDT https://www.sciencedaily.com/releases/2026/03/260321012659.htm https://www.sciencedaily.com/releases/2026/03/260311004720.htm Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody infusions like current therapies, the experimental treatment uses genetically engineered astrocytes — abundant support cells in the brain — that are equipped with a CAR “homing device” similar to those used in cancer immunotherapy. Wed, 11 Mar 2026 17:01:42 EDT https://www.sciencedaily.com/releases/2026/03/260311004720.htm https://www.sciencedaily.com/releases/2026/03/260302030648.htm Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system from destroying transplanted cells — without using immunosuppressive drugs. Backed by $1 million in funding, the team hopes to create a ready-to-use treatment that could work even for people who have had diabetes for years. The approach could transform how the disease is treated. Mon, 02 Mar 2026 11:49:16 EST https://www.sciencedaily.com/releases/2026/03/260302030648.htm https://www.sciencedaily.com/releases/2026/02/260215225555.htm Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects. Tue, 17 Feb 2026 05:30:08 EST https://www.sciencedaily.com/releases/2026/02/260215225555.htm https://www.sciencedaily.com/releases/2026/02/260212025550.htm A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many other symptoms appeared just as often in people taking a placebo. Only a few side effects showed any link to statins — and even those were rare. Sun, 15 Feb 2026 00:35:50 EST https://www.sciencedaily.com/releases/2026/02/260212025550.htm https://www.sciencedaily.com/releases/2026/02/260209064314.htm A long-term study of older adults with moderate hearing loss found that hearing aids did not lead to better performance on memory or thinking tests, but the story did not end there. Over seven years, people who were prescribed hearing aids were significantly less likely to develop dementia than those who were not. Mon, 09 Feb 2026 06:43:14 EST https://www.sciencedaily.com/releases/2026/02/260209064314.htm https://www.sciencedaily.com/releases/2026/02/260204121540.htm Researchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth. By testing every possible mutation in a critical hotspot, they found that some changes barely boost cancer signals, while others supercharge them. When matched against real patient data, the map accurately predicted cancer behavior across tissues. Thu, 05 Feb 2026 07:29:14 EST https://www.sciencedaily.com/releases/2026/02/260204121540.htm https://www.sciencedaily.com/releases/2026/01/260131084610.htm Statins are a cornerstone of heart health, but muscle pain and weakness cause many patients to quit taking them. Scientists have now identified the precise molecular trigger behind these side effects. They found that statins jam open a critical muscle protein, causing a toxic calcium leak. The discovery could lead to safer statins that keep their life-saving benefits without the muscle damage. Sat, 31 Jan 2026 10:39:49 EST https://www.sciencedaily.com/releases/2026/01/260131084610.htm https://www.sciencedaily.com/releases/2026/01/260128075323.htm Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research reveals a hidden trick: cancer cells can package the immune-blocking protein PD-L1 into tiny particles that circulate through the body and weaken immunotherapy’s impact. Scientists in Japan discovered that a little-known protein, UBL3, controls this process—and surprisingly, common cholesterol-lowering drugs called statins can shut it down. Wed, 28 Jan 2026 09:10:54 EST https://www.sciencedaily.com/releases/2026/01/260128075323.htm https://www.sciencedaily.com/releases/2026/01/260115022812.htm New research suggests statins may protect adults with type 2 diabetes regardless of how low their predicted heart risk appears. In a large UK study, statin use was linked to fewer deaths and major cardiac events across all risk levels. Even those labeled “low risk” benefited, challenging long-held assumptions about who should receive preventive therapy. Side effects were rare and generally mild. Thu, 15 Jan 2026 09:17:02 EST https://www.sciencedaily.com/releases/2026/01/260115022812.htm https://www.sciencedaily.com/releases/2026/01/260114084122.htm A new discovery may explain why so many people abandon cholesterol-lowering statins because of muscle pain and weakness. Researchers found that certain statins can latch onto a key muscle protein and trigger a tiny but harmful calcium leak inside muscle cells. That leak may weaken muscles directly or activate processes that slowly break them down, offering a long-sought explanation for statin-related aches. Wed, 14 Jan 2026 11:06:53 EST https://www.sciencedaily.com/releases/2026/01/260114084122.htm https://www.sciencedaily.com/releases/2026/01/260113220915.htm Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the risk of falls and confusion. A new study shows that while prescribing has decreased overall, people with cognitive impairment remain more likely to receive these drugs. In many cases, there was no documented medical justification. The results suggest that medication safety remains a serious concern in dementia care. Tue, 13 Jan 2026 23:17:46 EST https://www.sciencedaily.com/releases/2026/01/260113220915.htm https://www.sciencedaily.com/releases/2026/01/260112001041.htm Researchers have discovered a brain activity pattern that can predict which people with mild cognitive impairment are likely to develop Alzheimer’s disease. Using a noninvasive brain scanning technique and a custom analysis tool, they detected subtle changes in electrical signals tied to memory processing years before diagnosis. The findings point to a new way of spotting Alzheimer’s early—by listening directly to how neurons behave. Mon, 12 Jan 2026 09:24:19 EST https://www.sciencedaily.com/releases/2026/01/260112001041.htm https://www.sciencedaily.com/releases/2025/12/251228020016.htm Researchers discovered that clogged brain “drains” show up early in people at risk of Alzheimer’s disease. These blockages, easily seen on standard MRI scans, are tied to toxic protein buildup linked to memory loss and cognitive decline. In some cases, they may signal Alzheimer’s earlier than other commonly used brain markers. This could help physicians detect the disease earlier, before irreversible damage sets in. Sat, 03 Jan 2026 00:45:11 EST https://www.sciencedaily.com/releases/2025/12/251228020016.htm https://www.sciencedaily.com/releases/2025/12/251222080119.htm New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early damage in mice and reduces inflammation linked to disease progression. The treatment was given before symptoms appeared, targeting the disease at its earliest stage. Researchers say this approach could reshape how Alzheimer’s is prevented and treated. Mon, 22 Dec 2025 08:11:02 EST https://www.sciencedaily.com/releases/2025/12/251222080119.htm https://www.sciencedaily.com/releases/2025/12/251218060615.htm Spending a few hours a week helping others may slow the aging of the brain. Researchers found that both formal volunteering and informal acts, like helping neighbors or relatives, were linked to noticeably slower cognitive decline over time. The benefits added up year after year and didn’t require a huge time commitment. Even modest, everyday helping packed a powerful mental payoff. Fri, 19 Dec 2025 10:08:36 EST https://www.sciencedaily.com/releases/2025/12/251218060615.htm https://www.sciencedaily.com/releases/2025/11/251127010319.htm Scientists studying young adults with obesity discovered early indicators of brain stress that resemble patterns seen in cognitive impairment. The group showed higher inflammation, signs of liver strain and elevated neurofilament light chain, a marker of neuron injury. Low choline levels appeared closely tied to these changes. The results hint that early metabolic disruptions may quietly influence the brain long before symptoms emerge. Thu, 27 Nov 2025 02:45:12 EST https://www.sciencedaily.com/releases/2025/11/251127010319.htm https://www.sciencedaily.com/releases/2025/11/251123115708.htm Hypertension begins harming the brain surprisingly early, even before measurable blood pressure increases. Key cells related to blood vessels, signaling, and myelin maintenance begin aging prematurely and malfunctioning. These disruptions resemble early patterns seen in cognitive decline and Alzheimer’s. Encouragingly, losartan reversed some of this early damage in mice. Mon, 24 Nov 2025 09:33:36 EST https://www.sciencedaily.com/releases/2025/11/251123115708.htm https://www.sciencedaily.com/releases/2025/11/251121090731.htm Researchers discovered that the common amino acid arginine can block harmful Aβ aggregation and reduce its toxic effects in Alzheimer’s disease models. In flies and mice, oral arginine lowered plaque levels, reduced inflammation, and improved behavior. Its strong safety record and low cost make it a promising repurposing candidate. The findings hint at a surprisingly simple path toward more accessible AD therapies. Fri, 21 Nov 2025 11:33:04 EST https://www.sciencedaily.com/releases/2025/11/251121090731.htm https://www.sciencedaily.com/releases/2025/11/251118220052.htm Scientists have developed a new molecule that breaks down beta-amyloid plaques by binding to excess copper in the brain. The treatment restored memory and reduced inflammation in rats, while also proving non-toxic and able to cross the blood–brain barrier. Because it’s far simpler and potentially cheaper than existing drugs, researchers are now pursuing partnerships to begin human trials. Wed, 19 Nov 2025 10:46:50 EST https://www.sciencedaily.com/releases/2025/11/251118220052.htm https://www.sciencedaily.com/releases/2025/11/251118220049.htm Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to quietly gain dominance with age. Reprogrammed stromal cells and interferon-responsive T cells create a self-sustaining inflammatory loop that weakens blood production. Surprisingly, the mutant cells themselves may not be the main instigators. Tue, 18 Nov 2025 22:00:49 EST https://www.sciencedaily.com/releases/2025/11/251118220049.htm https://www.sciencedaily.com/releases/2025/11/251116105633.htm Older adults who regularly listen to or play music appear to have significantly lower risks of dementia and cognitive decline. The data suggests that musical engagement could be a powerful, enjoyable tool for supporting cognitive resilience in aging. Mon, 17 Nov 2025 09:31:10 EST https://www.sciencedaily.com/releases/2025/11/251116105633.htm https://www.sciencedaily.com/releases/2025/11/251111005944.htm Japanese researchers found that lecanemab, an amyloid-clearing drug for Alzheimer’s, does not improve the brain’s waste clearance system in the short term. This implies that nerve damage and impaired clearance occur early and are difficult to reverse. Their findings underscore that tackling amyloid alone may not be enough to restore brain function, urging a broader approach to treatment. Tue, 11 Nov 2025 01:47:33 EST https://www.sciencedaily.com/releases/2025/11/251111005944.htm https://www.sciencedaily.com/releases/2025/11/251104013008.htm Walking a few thousand steps daily may help hold off Alzheimer’s for years, a Mass General Brigham study found. Even moderate physical activity slowed both cognitive decline and the buildup of harmful tau proteins in the brain. The researchers say these results show lifestyle changes can meaningfully delay Alzheimer’s symptoms, especially in early stages. Tue, 04 Nov 2025 09:16:57 EST https://www.sciencedaily.com/releases/2025/11/251104013008.htm https://www.sciencedaily.com/releases/2025/10/251029100154.htm Researchers used supramolecular nanoparticles to repair the brain’s vascular system and reverse Alzheimer’s in mice. Instead of carrying drugs, the nanoparticles themselves triggered natural clearance of amyloid-β proteins. This restored blood-brain barrier function and reversed memory loss. The results point to a revolutionary new path for treating neurodegenerative diseases. Wed, 29 Oct 2025 10:01:54 EDT https://www.sciencedaily.com/releases/2025/10/251029100154.htm https://www.sciencedaily.com/releases/2025/10/251022023113.htm Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer’s disease begins. The two proteins together create stubborn clots that damage blood vessels and spark inflammation in the brain. These effects appear even at very low concentrations and disrupt the blood-brain barrier, paving the way for neurodegeneration. The findings highlight a potential new therapeutic target for early intervention. Wed, 22 Oct 2025 09:19:26 EDT https://www.sciencedaily.com/releases/2025/10/251022023113.htm https://www.sciencedaily.com/releases/2025/10/251010091555.htm A surprising link between Alzheimer’s and cancer reveals that amyloid beta, a harmful protein in the brain, actually empowers the immune system. It strengthens T-cells’ energy production, helping them fight cancer more effectively. By restoring fumarate levels or transplanting healthy mitochondria, researchers may be able to rejuvenate aging immune cells. These findings could inspire a new generation of treatments that target both cancer and age-related decline. Fri, 10 Oct 2025 09:15:55 EDT https://www.sciencedaily.com/releases/2025/10/251010091555.htm https://www.sciencedaily.com/releases/2025/09/250927031227.htm Living with a sense of purpose may not just enrich life, it could also guard against dementia. A UC Davis study tracking over 13,000 adults for up to 15 years found that people with higher purpose were about 28% less likely to develop cognitive impairment. Purpose was linked to resilience across ethnicities, even in those with genetic risks for Alzheimer’s, and activities like relationships, volunteering, spirituality, and personal goals can help nurture it. Sun, 28 Sep 2025 04:06:56 EDT https://www.sciencedaily.com/releases/2025/09/250927031227.htm https://www.sciencedaily.com/releases/2025/09/250924012257.htm For decades, scientists believed Alzheimer’s was driven mainly by sticky protein plaques and tangles in the brain. Now Purdue researchers have revealed a hidden culprit: fat. They found that brain immune cells can become clogged with fat, leaving them too weak to fight off disease. By clearing out this fat and restoring the cells’ defenses, researchers may have uncovered an entirely new way to combat Alzheimer’s — shifting the focus from plaques alone to how the brain handles fat. Wed, 24 Sep 2025 23:56:50 EDT https://www.sciencedaily.com/releases/2025/09/250924012257.htm https://www.sciencedaily.com/releases/2025/09/250920214459.htm New studies reveal that lifestyle changes—such as exercise, healthy eating, and social engagement—can help slow or prevent cognitive decline. Experts say this low-cost, powerful approach could transform dementia care and reduce its crushing toll on families and health systems. Sun, 21 Sep 2025 09:42:01 EDT https://www.sciencedaily.com/releases/2025/09/250920214459.htm https://www.sciencedaily.com/releases/2025/09/250913232924.htm Chronic insomnia may do more than leave you groggy, it could speed up brain aging. A large Mayo Clinic study found that people with long-term sleep troubles were 40% more likely to develop dementia or cognitive impairment, with brain scans showing changes linked to Alzheimer’s. Those reporting reduced sleep showed declines comparable to being four years older, while certain genetic risk carriers saw even steeper drops. Sun, 14 Sep 2025 02:02:57 EDT https://www.sciencedaily.com/releases/2025/09/250913232924.htm https://www.sciencedaily.com/releases/2025/09/250909031511.htm Scientists discovered that certain blood proteins linked to brain injury and inflammation strongly correlate with early signs of memory and cognitive decline, especially in Hispanic and Latino adults. This breakthrough points to a future where Alzheimer’s could be detected early with a simple blood test. Tue, 09 Sep 2025 22:05:55 EDT https://www.sciencedaily.com/releases/2025/09/250909031511.htm https://www.sciencedaily.com/releases/2025/08/250831010539.htm Beta blockers, used for decades after heart attacks, provide no benefit for patients with preserved heart function, according to the REBOOT trial. The massive study also found women faced higher risks when taking the drug. Experts say the results will change heart treatment guidelines worldwide. Sun, 31 Aug 2025 11:03:07 EDT https://www.sciencedaily.com/releases/2025/08/250831010539.htm https://www.sciencedaily.com/releases/2025/08/250829022829.htm Harvard scientists have uncovered that lithium, a naturally occurring element in the brain, may be the missing piece in understanding Alzheimer’s. Their decade-long research shows that lithium depletion—caused by amyloid plaques binding to it—triggers early brain changes that lead to memory loss. By testing new lithium compounds that evade plaque capture, they reversed Alzheimer’s-like damage and restored memory in mice at doses far lower than those used in psychiatric treatments. Fri, 29 Aug 2025 02:57:32 EDT https://www.sciencedaily.com/releases/2025/08/250829022829.htm https://www.sciencedaily.com/releases/2025/08/250822073817.htm St. Jude researchers revealed that midkine blocks amyloid beta from forming harmful clumps linked to Alzheimer’s. Without it, the damaging assemblies accelerate, but with it, growth halts. The finding could inspire new drugs that harness midkine’s protective power. Sat, 23 Aug 2025 10:21:32 EDT https://www.sciencedaily.com/releases/2025/08/250822073817.htm https://www.sciencedaily.com/releases/2025/08/250802022917.htm In a fascinating twist, Mayo Clinic researchers discovered that a sugar molecule cancer cells use to hide from the immune system might also protect insulin-producing beta cells in type 1 diabetes. By engineering these cells with the same sugar molecule—sialic acid—they prevented immune attacks in lab models. This approach could lead to better transplant options without broad immune suppression, offering hope for millions living with the autoimmune disease. Sat, 02 Aug 2025 09:39:45 EDT https://www.sciencedaily.com/releases/2025/08/250802022917.htm https://www.sciencedaily.com/releases/2025/07/250730030356.htm Potent statins are the best-proven weapon against heart disease, especially when paired with lifestyle changes. Most people aren’t active enough—and many are underdiagnosed—so starting treatment strong is key. Wed, 30 Jul 2025 23:57:41 EDT https://www.sciencedaily.com/releases/2025/07/250730030356.htm https://www.sciencedaily.com/releases/2025/07/250717013905.htm A massive European study has uncovered a powerful connection between hearing loss, loneliness, and memory decline. Researchers at the University of Geneva found that older adults with hearing impairments who also feel lonely—regardless of actual social isolation—experience faster cognitive decline. Fri, 18 Jul 2025 00:20:12 EDT https://www.sciencedaily.com/releases/2025/07/250717013905.htm https://www.sciencedaily.com/releases/2025/07/250706230311.htm When you're mentally exhausted, your brain might be doing more behind the scenes than you think. In a new study using functional MRI, researchers uncovered two key brain regions that activate when people feel cognitively fatigued—regions that appear to weigh the cost of continuing mental effort versus giving up. Surprisingly, participants needed high financial incentives to push through challenging memory tasks, hinting that motivation can override mental fatigue. These insights may pave the way to treating brain fog in disorders like PTSD and depression using brain imaging and behavior-based therapies. Mon, 07 Jul 2025 04:34:10 EDT https://www.sciencedaily.com/releases/2025/07/250706230311.htm https://www.sciencedaily.com/releases/2025/06/250629033408.htm USC researchers have found a promising new brain scan marker that could better detect Alzheimer’s risk — but only for some. The tau-based benchmark works in Hispanic and White populations when paired with another Alzheimer’s protein, amyloid, but falls short for Black participants, revealing critical gaps in current diagnostics. Sun, 29 Jun 2025 04:13:30 EDT https://www.sciencedaily.com/releases/2025/06/250629033408.htm https://www.sciencedaily.com/releases/2025/06/250622224303.htm A simple blood test could reveal which early Alzheimer’s patients are most at risk for rapid decline. Researchers found that people with high insulin resistance—measured by the TyG index—were four times more likely to experience faster cognitive deterioration. The study highlights a major opportunity: a common lab value already available in hospitals could help guide personalized treatment strategies. This discovery also uncovers a unique vulnerability in Alzheimer’s disease to metabolic stress, offering new possibilities for intervention while the disease is still in its early stages. Sun, 22 Jun 2025 22:43:03 EDT https://www.sciencedaily.com/releases/2025/06/250622224303.htm https://www.sciencedaily.com/releases/2025/05/250523120353.htm Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies. Fri, 23 May 2025 12:03:53 EDT https://www.sciencedaily.com/releases/2025/05/250523120353.htm https://www.sciencedaily.com/releases/2025/05/250521124752.htm Bats are known as natural hosts for highly pathogenic viruses such as MERS- and SARS-related coronaviruses, as well as the Marburg and Nipah viruses. In contrast to the severe and often fatal disease outcomes these viruses cause in humans, bats generally do not show obvious signs of viral illness following infection. An international research team has developed an innovative organoid research platform that allowed them to closely investigate the cellular antiviral defense mechanisms of mucosal epithelial tissues of bats. The results could pave the way for the development of new therapies against viral diseases. Wed, 21 May 2025 12:47:52 EDT https://www.sciencedaily.com/releases/2025/05/250521124752.htm https://www.sciencedaily.com/releases/2025/05/250516133225.htm While Alzheimer's disease is mostly considered a disorder of the brain, emerging evidence suggests that the condition also affects other organs of the body. Working with the laboratory fruit fly, researchers provide a new understanding of how Alzheimer's disease affects different tissues across the entire body. The findings reveal new insights into brain-body communication in neurodegeneration and pave the way for identifying novel biomarkers and therapeutic targets for Alzheimer's disease. Fri, 16 May 2025 13:32:25 EDT https://www.sciencedaily.com/releases/2025/05/250516133225.htm https://www.sciencedaily.com/releases/2025/05/250512133656.htm Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it. Mon, 12 May 2025 13:36:56 EDT https://www.sciencedaily.com/releases/2025/05/250512133656.htm https://www.sciencedaily.com/releases/2025/04/250424120851.htm In a landmark clinical trial people at risk for Alzheimer's who exercised at low or moderate-high intensity showed less cognitive decline when compared to those receiving usual care. Thu, 24 Apr 2025 12:08:51 EDT https://www.sciencedaily.com/releases/2025/04/250424120851.htm https://www.sciencedaily.com/releases/2025/04/250423112628.htm People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a new study. Wed, 23 Apr 2025 11:26:28 EDT https://www.sciencedaily.com/releases/2025/04/250423112628.htm https://www.sciencedaily.com/releases/2025/04/250423111918.htm Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk of dying from their cancer compared to similar patients who were not taking statins, according to a new study. Wed, 23 Apr 2025 11:19:18 EDT https://www.sciencedaily.com/releases/2025/04/250423111918.htm https://www.sciencedaily.com/releases/2025/04/250421162929.htm A new study suggests that risk factors and biomarkers related to Alzheimer's disease are associated with cognition much earlier in life than previously recognized. The study highlights significant associations between cognition and Alzheimer's disease risk factors as young as ages 24 to 44 and underscores the importance of early prevention. This is the first study to systematically examine Alzheimer's disease risk factors, including biomarkers related to cognitive impairment in a large group of generally healthy middle-aged individuals in the U.S. Mon, 21 Apr 2025 16:29:29 EDT https://www.sciencedaily.com/releases/2025/04/250421162929.htm https://www.sciencedaily.com/releases/2025/04/250418112635.htm When the immune system does not function properly, individuals become more susceptible to infections caused by viruses, bacteria, or fungi. Researchers have demonstrated that an existing drug can revive immune cells that are not functioning correctly. These findings provide leads for further research in patients admitted to the intensive care unit (ICU) with sepsis. Fri, 18 Apr 2025 11:26:35 EDT https://www.sciencedaily.com/releases/2025/04/250418112635.htm https://www.sciencedaily.com/releases/2025/04/250417145247.htm Among adults ages 18-49 (median age of 41 years) who were born with a hole in the upper chambers of their heart known as patent foramen ovale (PFO), strokes of unknown cause were more strongly associated with nontraditional risk factors, such as migraines, liver disease or cancer, rather than more typical factors such as high blood pressure. Thu, 17 Apr 2025 14:52:47 EDT https://www.sciencedaily.com/releases/2025/04/250417145247.htm https://www.sciencedaily.com/releases/2025/04/250416135456.htm Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms. This is evident in the levels of the protein 'beta-synuclein'. Wed, 16 Apr 2025 13:54:56 EDT https://www.sciencedaily.com/releases/2025/04/250416135456.htm https://www.sciencedaily.com/releases/2025/04/250414124347.htm Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests. Mon, 14 Apr 2025 12:43:47 EDT https://www.sciencedaily.com/releases/2025/04/250414124347.htm https://www.sciencedaily.com/releases/2025/04/250408121324.htm Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves neuron health in animal models of Alzheimer's disease, according to a new study. Tue, 08 Apr 2025 12:13:24 EDT https://www.sciencedaily.com/releases/2025/04/250408121324.htm https://www.sciencedaily.com/releases/2025/04/250407114219.htm Findings from a new study could help doctors select more effective treatments earlier for patients suffering from leishmaniasis, a disfiguring skin infection. Mon, 07 Apr 2025 11:42:19 EDT https://www.sciencedaily.com/releases/2025/04/250407114219.htm https://www.sciencedaily.com/releases/2025/04/250403122639.htm There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study suggests. Global cognition and executive functioning declined more rapidly over the years after heart failure diagnosis, as people with the condition mentally aged the equivalent of 10 years within just seven years of a heart failure diagnosis. Thu, 03 Apr 2025 12:26:39 EDT https://www.sciencedaily.com/releases/2025/04/250403122639.htm